Skip to main content
Premium Trial:

Request an Annual Quote

PamGene Licenses Microarray Platform to Nottingham University

NEW YORK, July 12 (GenomeWeb News) - PamGene International said today that it has licensed its 3-dimensional, flow-through microarray platform to NottinghamUniversity in England.

 

According to the company, the service license includes the sale of a PamGene 4-array PamStation and will allow the university to develop multiplex amplifiable probe hybridization as a service on the PamGene platform.

 

Financial terms of the licensing deal were not disclosed.

 

PamGene noted that Nottingham University will initially use the PamStation for internal MAPH research, and plans on begin offering services through a company to be spun out of the university's institute of genetics in the near future.

 

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.